User profiles for Ebrahim Azizi

Ebrahim Azizi

University of Michigan and Tehran University of Medical Sciences
Verified email at med.umich.edu
Cited by 5456

Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

HJ Yoon, TH Kim, Z Zhang, E Azizi, TM Pham… - Nature …, 2013 - nature.com
The spread of cancer throughout the body is driven by circulating tumour cells (CTCs) 1 .
These cells detach from the primary tumour and move from the bloodstream to a new site of …

Evaluation of oxidative stress and genotoxicity in organophosphorus insecticide formulators

S Shadnia, E Azizi, R Hosseini… - Human & …, 2005 - journals.sagepub.com
The aim of this study was to evaluate genotoxicity and oxidative stress in workers who formulate
organophosphorus (OP) pesticides. In this survey, blood leukocytes and erythrocytes of …

Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization

T Gazori, MR Khoshayand, E Azizi, P Yazdizade… - Carbohydrate …, 2009 - Elsevier
Nanoparticles comprising Alginate/Chitosan polymers were prepared by pregel preparation
method through drop wise addition of various concentrations of CaCl 2 to a defined …

[HTML][HTML] Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model

…, H Shiratsuchi, J Lin, G Chen, RM Reddy, E Azizi… - Oncotarget, 2014 - ncbi.nlm.nih.gov
The potential utility of circulating tumor cells (CTCs) to guide clinical care in oncology patients
has gained momentum with emerging micro-and nanotechnologies. Establishing the role …

Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers

…, DG Beer, MS Wicha, N Ramnath, E Azizi… - Cancer research, 2017 - AACR
Early detection of metastasis can be aided by circulating tumor cells (CTC), which also show
potential to predict early relapse. Because of the limited CTC numbers in peripheral blood …

Cell‐penetrating peptides as a novel transdermal drug delivery system

SA Nasrollahi, C Taghibiglou, E Azizi… - Chemical biology & …, 2012 - Wiley Online Library
In the last decade, almost one‐third of the newly discovered drugs approved by the US FDA
were biomolecules and biologics. Effective delivery of therapeutic biomolecules to their …

[HTML][HTML] Tunable thermal-sensitive polymer-graphene oxide composite for efficient capture and release of viable circulating tumor cells

…, Q Jin, N Palanisamy, ML Burness, E Azizi… - … (Deerfield Beach, Fla …, 2016 - ncbi.nlm.nih.gov
With over 1600 people dying of cancer in the United States every day,[1] the prevention of
the second leading cause of death is a clear area of research interest in the medical …

[HTML][HTML] PD-L1 expression in circulating tumor cells increases during radio (chemo) therapy and indicates poor prognosis in non-small cell lung cancer

…, S Fouladdel, Z Zhang, P Soni, A Qin, L Zhao, E Azizi… - Scientific reports, 2019 - nature.com
Preclinical studies demonstrated that radiation up-regulates PD-L1 expression in tumor cells,
providing a rationale for combining PD-1/PD-L1 inhibitors with radiation. However this has …

[PDF][PDF] Heterogeneity of human breast stem and progenitor cells as revealed by transcriptional profiling

JA Colacino, E Azizi, MD Brooks, R Harouaka… - Stem cell reports, 2018 - cell.com
During development, the mammary gland undergoes extensive remodeling driven by stem
cells. Breast cancers are also hierarchically organized and driven by cancer stem cells …

Breast cancer stem cells: current advances and clinical implications

…, SG Clouthier, Y Deol, S Liu, S Nagrath, E Azizi… - Mammary Stem Cells …, 2015 - Springer
There is substantial evidence that many cancers, including breast cancer, are driven by a
population of cells that display stem cell properties. These cells, termed cancer stem cells (…